ACET
Price
$0.74
Change
-$0.02 (-2.63%)
Updated
Aug 29, 11:23 AM (EDT)
Capitalization
63.16M
68 days until earnings call
IRWD
Price
$1.32
Change
+$0.06 (+4.76%)
Updated
Aug 28 closing price
Capitalization
214.41M
69 days until earnings call
Interact to see
Advertisement

ACET vs IRWD

Header iconACET vs IRWD Comparison
Open Charts ACET vs IRWDBanner chart's image
Adicet Bio
Price$0.74
Change-$0.02 (-2.63%)
Volume$595
Capitalization63.16M
Ironwood Pharmaceuticals
Price$1.32
Change+$0.06 (+4.76%)
Volume$901.31K
Capitalization214.41M
ACET vs IRWD Comparison Chart in %
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. IRWD commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a StrongBuy and IRWD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ACET: $0.76 vs. IRWD: $1.32)
Brand notoriety: ACET and IRWD are both not notable
ACET represents the Biotechnology, while IRWD is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ACET: 41% vs. IRWD: 61%
Market capitalization -- ACET: $63.16M vs. IRWD: $214.41M
ACET [@Biotechnology] is valued at $63.16M. IRWD’s [@Pharmaceuticals: Generic] market capitalization is $214.41M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 1 FA rating(s) are green whileIRWD’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 1 green, 4 red.
  • IRWD’s FA Score: 0 green, 5 red.
According to our system of comparison, ACET is a better buy in the long-term than IRWD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 7 TA indicator(s) are bullish while IRWD’s TA Score has 4 bullish TA indicator(s).

  • ACET’s TA Score: 7 bullish, 3 bearish.
  • IRWD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ACET is a better buy in the short-term than IRWD.

Price Growth

ACET (@Biotechnology) experienced а +11.12% price change this week, while IRWD (@Pharmaceuticals: Generic) price change was +11.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.09%, and the average quarterly price growth was +29.14%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.15%. For the same industry, the average monthly price growth was +68.06%, and the average quarterly price growth was +81.85%.

Reported Earning Dates

ACET is expected to report earnings on Nov 05, 2025.

IRWD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Generic (+1.15% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRWD($214M) has a higher market cap than ACET($63.2M). ACET YTD gains are higher at: -21.143 vs. IRWD (-70.203). IRWD has higher annual earnings (EBITDA): 79.6M vs. ACET (-112.08M). ACET has more cash in the bank: 125M vs. IRWD (92.9M). ACET has less debt than IRWD: ACET (15.4M) vs IRWD (599M). IRWD has higher revenues than ACET: IRWD (309M) vs ACET (0).
ACETIRWDACET / IRWD
Capitalization63.2M214M30%
EBITDA-112.08M79.6M-141%
Gain YTD-21.143-70.20330%
P/E RatioN/A92.69-
Revenue0309M-
Total Cash125M92.9M135%
Total Debt15.4M599M3%
FUNDAMENTALS RATINGS
ACET vs IRWD: Fundamental Ratings
ACET
IRWD
OUTLOOK RATING
1..100
522
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
80
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6338
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (28) in the Medical Distributors industry is somewhat better than the same rating for IRWD (80) in the Pharmaceuticals Other industry. This means that ACET’s stock grew somewhat faster than IRWD’s over the last 12 months.

ACET's Profit vs Risk Rating (100) in the Medical Distributors industry is in the same range as IRWD (100) in the Pharmaceuticals Other industry. This means that ACET’s stock grew similarly to IRWD’s over the last 12 months.

ACET's SMR Rating (100) in the Medical Distributors industry is in the same range as IRWD (100) in the Pharmaceuticals Other industry. This means that ACET’s stock grew similarly to IRWD’s over the last 12 months.

IRWD's Price Growth Rating (38) in the Pharmaceuticals Other industry is in the same range as ACET (63) in the Medical Distributors industry. This means that IRWD’s stock grew similarly to ACET’s over the last 12 months.

IRWD's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as ACET (100) in the Medical Distributors industry. This means that IRWD’s stock grew similarly to ACET’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETIRWD
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
68%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 8 days ago
67%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 15 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
75%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORPB9.500.30
+3.26%
Oregon Pacific Bancorp
DLICY16.940.19
+1.14%
Dai-ichi Life Holdings, Inc.
NRKBY13.80N/A
N/A
NKT A/S
SLDX0.02N/A
N/A
STELLA DIAGNOSTICS INC.
TNIEF7.06N/A
N/A
TONIES SE

IRWD and

Correlation & Price change

A.I.dvisor tells us that IRWD and ACET have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRWD and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
+4.76%
ACET - IRWD
30%
Poorly correlated
+0.40%
PRGO - IRWD
29%
Poorly correlated
-0.54%
ASRT - IRWD
26%
Poorly correlated
+5.32%
ELAN - IRWD
24%
Poorly correlated
-0.22%
HROW - IRWD
24%
Poorly correlated
+0.52%
More